| |
| Issue |
Title |
| |
| No 15 (2025) |
Phytotherapy in chronic liver diseases |
Abstract
PDF (Rus)
|
|
T. E. Polunina |
| |
| No 15 (2025) |
Modern aspects of management of patients with metabolic dysfunction-associated steatotic liver disease |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, A. V. Vasyutin, J. L. Tonkikh |
| |
| No 15 (2025) |
Evaluation of the efficacy and safety of succinates in drug-induced liver injury: A systematic review |
Abstract
PDF (Rus)
|
|
E. K. Krasova, E. A. Kovaleva, S. V. Okovityi |
| |
| No 15 (2025) |
A new look at the classification of gallstone disease |
Abstract
PDF (Rus)
|
|
S. N. Mekhtiev, O. A. Mekhtieva |
| |
| No 15 (2025) |
Liver fibrosis as a major prognostic factor in chronic liver diseases and a key target for pharmacotherapy |
Abstract
PDF (Rus)
|
|
S. N. Mekhtiev, O. A. Mekhtieva, O. M. Berko, A. S. Lovitskiy |
| |
| No 15 (2025) |
Prevalence of non-alcoholic fatty liver disease at Moscow multi-speciality hospitals from 2022 to 2024 |
Abstract
PDF (Rus)
|
|
D. T. Dicheva, R. M. Brekhunets, D. N. Andreev, E. G. Lebedeva, O. E. Berezutskaya, N. L. Golovkina, R. I. Shaburov, S. V. Cheremushkin, I. V. Maev |
| |
| No 8 (2025) |
Diagnostic accuracy of predictive indices for assessing liver steatosis and fibrosis as compared to transient elastography in patients with non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
R. M. Brekhunets, D. N. Andreev, I. V. Maev, D. T. Dicheva, A. K. Kulieva |
| |
| No 8 (2025) |
Validation of the FibroScan-AST (FAST) and Agile 3+ score in metabolic dysfunction-associated steatotic liver disease in a Russian cohort of patients |
Abstract
PDF (Rus)
|
|
V. P. Gomonova, K. L. Raikhelson, V. A. Kashchenko, A. V. Lodygin, V. E. Karev |
| |
| No 8 (2025) |
Metabolic-associated fatty liver disease: Noninvasive diagnosis and assessment of liver fibrosis |
Abstract
PDF (Rus)
|
|
O. O. Karshina, I. S. Sabirov |
| |
| No 8 (2025) |
The effect of corticosteroid therapy on the development of liver cirrhosis: A clinical case |
Abstract
PDF (Rus)
|
|
O. S. Skuratova, Yu. S. Samoilova, V. V. Reutskaya, M. S. Samoilov, S. N. Lagutina, A. A. Pashkova |
| |
| No 8 (2025) |
Association of clinical manifestations of Opisthorchis felineus invasion with elevated FIB-4 index levels |
Abstract
PDF (Rus)
|
|
N. E. Veselova, V. V. Tsukanov, A. A. Savchenko, A. V. Vasyutin, Ju. L. Tonkikh, Ya. E. Fursova |
| |
| No 8 (2025) |
Evaluation of the efficacy of a hepatoprotector for the treatment of toxic (drug-induced) liver injury |
Abstract
PDF (Rus)
|
|
A. I. Pavlov, A. S. Balabanov, V. E. Bakirova, A. G. Karakozov, D. N. Andreev, A. I. Molodova, M. N. Eremin |
| |
| No 8 (2025) |
Morpholinium thiazotati in the treatment of liver diseases and combined liver and heart diseases (narrative review) |
Abstract
PDF (Rus)
|
|
М. V. Maevskaya, S. V. Okovityy, V. A. Prikhodko |
| |
| No 8 (2025) |
L-Ornithine salts as somatotropic axis modulators for the correction of sarcopenia in chronic liver disease |
Abstract
PDF (Rus)
|
|
V. A. Prikhodko, S. V. Okovityi |
| |
| No 8 (2025) |
Alcoholic liver disease as a global health problem: Pathogenesis, diagnosis, and modern treatment approaches |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, V. V. Kolomytsev, L. V. Goryunova |
| |
| No 15 (2024) |
Blood MAIT cells phenotype in patients with Opisthorchis felineus invasion depending on the severity of liver fibrosis |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, N. E. Veselova, A. V. Vasyutin, A. Savchenko, J. L. Tonkikh, A. G. Borisov |
| |
| No 15 (2024) |
The interrelation of cardiometabolic risk factors and metabolic dysfunction-associated steatotic liver disease subtypes |
Abstract
PDF (Rus)
|
|
A. Yu. Ishchenko, M. Yu. Galushko, I. G. Bakulin |
| |
| No 15 (2024) |
Possibilities of treating sarcopenia in liver cirrhosis with hypoammonemic agents |
Abstract
PDF (Rus)
|
|
A. S. Ostrovskaya, M. V. Maevskaya, K. M. Loban, M. S. Zharkova, M. P. Shapka, E. A. Vasiltsova, Yu. O. Chvileva, V. T. Ivashkin |
| |
| No 15 (2024) |
Association of neutropenia and decreased neutrophil function with liver fibrosis in patients with Opisthorchis felineus invasion |
Abstract
PDF (Rus)
|
|
A. V. Vasyutin, V. V. Tsukanov, N. E. Veselova, E. G. Gorchilova, J. L. Tonkikh, A. A. Savchenko, A. G. Borisov |
| |
| No 15 (2024) |
Metabolic dysfunction-associated steatotic liver disease and drug-induced injuries: Pathogenetic aspects, treatment and prevention |
Abstract
PDF (Rus)
|
|
I. G. Pakhomova |
| |
| No 15 (2024) |
Diagnostic models for differentiating fatty liver disease of alcohol and non-alcoholic genesis |
Abstract
PDF (Rus)
|
|
M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. V. Belkovets, E. V. Kruchinina |
| |
| No 15 (2024) |
Gallstone disease: current pharmacotherapy options |
Abstract
PDF (Rus)
|
|
O. N. Minushkin, L. V. Maslovskii, T. B. Topchiy, E. G. Burdina, M. A. Kruchinina, L. I. Chugunnikova |
| |
| No 15 (2024) |
Prognostic value of the neutrophil to lymphocyte ratio in the development of systemic inflammatory response syndrome and death in patients with liver cirrhosis |
Abstract
PDF (Rus)
|
|
M. R. Sarkarova, M. V. Maevskaya |
| |
| No 15 (2024) |
Reduction of the risk of biliary lithiasis caused by various weight reduction options in obesity |
Abstract
PDF (Rus)
|
|
E. Yu. Plotnikova, A. S. Sukhikh |
| |
| No 15 (2024) |
Upper limb SMI for sarcopenia diagnosis in liver cirrhosis |
Abstract
PDF (Rus)
|
|
A. S. Ostrovskaya, M. V. Maevskaya, K. M. Loban, M. S. Zharkova, M. P. Shapka, M. Yu. Nadinskaia, K. A. Gulyaeva, E. A. Vasiltsova, Yu. O. Chvileva, V. T. Ivashkin |
| |
| No 8 (2024) |
Biliary tract dysfunctions: Possibilities of combined drugs of plant origin as advantage therapy |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, M. Yu. Rozhkova, Iu. G. Samoilova, O. A. Oleynik, M. V. Matveeva |
| |
| No 8 (2024) |
Traits of the lipid peroxidation – antioxidant defence system in non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
O. V. Smirnova, D. V. Lagutinskaya, I. E. Kasparova |
| |
| No 8 (2024) |
Prognostic value of the neutrophil to lymphocyte ratio in the clinical course of liver cirrhosis |
Abstract
PDF (Rus)
|
|
M. R. Sarkarova, M. V. Maevskaya |
| |
| No 8 (2024) |
“Dark and bright sides” of Gilbert’s syndrome |
Abstract
PDF (Rus)
|
|
E. Yu. Plotnikova, M. N. Sinkova, L. K. Isakov |
| |
| No 8 (2024) |
Clinical experience of using Polysorb in complex pathogenetic therapy of chronic hepatitis C with severe liver fibrosis |
Abstract
PDF (Rus)
|
|
D. Yu. Konstantinov, L. L. Popova, S. Yu. Vasilev, M. A. Popilov |
| |
| No 8 (2024) |
Features of the course of non-alcoholic fatty liver disease in women at different age periods: literature review |
Abstract
PDF (Rus)
|
|
I. A. Bulatova, T. P. Shevlyukova |
| |
| No 8 (2024) |
Acute alcoholic hepatitis – the role of modern hepatoprotectors |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, E. M. Skvortsova, V. V. Kolomytsev, L. V. Goryunova |
| |
| No 8 (2024) |
The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
T. S. Krolevets, M. A. Livzan, M. I. Syrovenko |
| |
| No 8 (2024) |
Modern pharmacotherapy for cholestasis syndrome |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, A. A. Eremenko, M. V. Vinogradova |
| |
| No 8 (2024) |
Identification of relapse predictors of IgG4-related sclerosing cholangitis |
Abstract
PDF (Rus)
|
|
A. K. Guseva, A. V. Okhlobystin |
| |
| No 18 (2023) |
Influence of liver attenuation on the severity of course COVID-19: a retrospective cohort study |
Abstract
PDF (Rus)
|
|
Yu. F. Shumskaya, A. P. Gonchar, M. G. Mnatsakanyan, I. A. Blokhin, R. V. Reshetnikov, Yu. A. Vasilev |
| |
| No 18 (2023) |
Features of the fatty acid profile of erythrocyte membranes in patients with fatty liver disease of alcoholic genesis |
Abstract
PDF (Rus)
|
|
M. V. Kruchinina, M. V. Parulikova, A. V. Belkovets, K. Yu. Nikolaev, A. K. Ovsyannikova |
| |
| No 18 (2023) |
Possibilities of modern pharmacotherapy in patients with dysfunction of the sphincter of Oddi |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, V. V. Kolomytsev, L. V. Goryunova |
| |
| No 18 (2023) |
Comparative characteristics of the triglyceride-glucose index and the homeostatic index of insulin resistance in various forms of non-alcoholic fatty liver disease |
Abstract
PDF (Rus)
|
|
A. A. Shipovskaya, I. V. Kurbatova, N. A. Larina, O. P. Dudanova |
| |
| No 18 (2023) |
Non-alcoholic fatty liver disease and the risk of malignant tumors |
Abstract
PDF (Rus)
|
|
M. A. Livzan, M. I. Syrovenko, T. S. Krolevets |
| |
| No 18 (2023) |
The role of phytocomponents in the complex therapy of chronic non-calculous cholecystitis |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, E. A. Malyakina, G. I. Malyakin |
| |
| No 18 (2023) |
Subpopulation composition of blood NK cells in patients with hepatitis C with genotype 1 or 3 |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, M. A. Cherepnin, A. A. Savchenko, A. V. Vasyutin, E. V. Kasparov, A. G. Borisov, V. D. Belenyuk, Ju. L. Tonkikh |
| |
| No 18 (2023) |
Sarcopenia and malnutrition in patients with liver diseases |
Abstract
PDF (Rus)
|
|
A. S. Ostrovskaya, M. V. Maevskaya |
| |
| No 8 (2023) |
Ursodeoxycholic acid: unique properties and clinical applications |
Abstract
PDF (Rus)
|
|
M. V. Maevskay |
| |
| No 8 (2023) |
Indicators of the hemostasis system and markers of endothelial damage in patients with steatosis and liver fibrosis |
Abstract
PDF (Rus)
|
|
I. A. Bulatova, T. P. Shevlyukova, I. L. Gulyaeva, A. A. Sobol, S. V. Paducheva |
| |
| No 8 (2023) |
The influence of structural and functional albumin properties on the life quality in patients with decompensated liver cirrhosis |
Abstract
PDF (Rus)
|
|
A. A. Turkina, M. V. Maevskaya, M. S. Zharkova, V. T. Ivashkin |
| |
| No 8 (2023) |
Polymorphisms of HSD17B13, GCKR, HFE, and CP as factors of the development of non-alcoholic fatty liver disease and comorbid diseases |
Abstract
PDF (Rus)
|
|
O. V. Smirnova, D. V. Lagutinskaya |
| |
| No 8 (2023) |
Risk stratification in alcoholic cirrhosis of the liver: a case study |
Abstract
PDF (Rus)
|
|
T. E. Polunina |
| |
| No 8 (2023) |
Efficiency of glucocorticosteroids in severe alcoholic hepatitis |
Abstract
PDF (Rus)
|
|
A. S. Rodina, I. V. Kurbatova, M. E. Shubina, O. P. Dudanova |
| |
| No 8 (2023) |
Subpopulation composition of blood T-killers in patients with hepatitis C with genotype 1 or 3 |
Abstract
PDF (Rus)
|
|
M. A. Cherepnin, V. V. Tsukanov, A. A. Savchenko, A. V. Vasyutin, A. G. Borisov, V. D. Belenyuk, J. L. Tonkikh |
| |
| No 8 (2023) |
Hyperferritinemia, chronic hepatitis C and COVID-19: what do they have in common? |
Abstract
PDF (Rus)
|
|
M. I. Gonik, E. L. Bueverova, A. O. Bueverov |
| |
| No 8 (2023) |
Generic drugs of direct antiviral action for the treatment of hepatitis C: features of bioequivalence studies |
Abstract
PDF (Rus)
|
|
N. N. Eremenko, N. E. Uvarova, S. Yu. Serebrova, E. Yu. Demchenkova, E. V. Shikh |
| |
| No 15 (2021) |
The biliary continuum: an up-to-date look at biliary tract diseases |
Abstract
PDF (Rus)
|
|
I. V. Maev, D. S. Bordin, T. A. Ilchishina, Yu. A. Kucheryavyy |
| |
| No 15 (2021) |
Genetic predictors and pathophysiological features of non-alcoholic fat liver disease |
Abstract
PDF (Rus)
|
|
O. V. Smirnova, O. L. Moskalenko, E. V. Kasparov, I. E. Kasparova, |
| |
| No 15 (2021) |
Cause-and-effect relationship between thyroid and liver diseases |
Abstract
PDF (Rus)
|
|
A. O. Bueverov, P. O. Bogomolov, O. A. Nechayeva, A. V. Zilov |
| |
| No 15 (2021) |
Postcholecystectomy syndrome, dynamics of ideas, diagnostics, treatment |
Abstract
PDF (Rus)
|
|
O. N. Minushkin |
| |
| No 15 (2021) |
Hepatic encephalopathy: issues relevant to clinical practice |
Abstract
PDF (Rus)
|
|
M. V. Maevskaya |
| |
| No 15 (2021) |
Liver drug damage: possibilities of polyionic succinate-methioninic complex during the pandemic of new coronavirus infection (COVID-19) |
Abstract
PDF (Rus)
|
|
D. I. Trukhan, E. L. Davydov |
| |
| No 15 (2021) |
Hepatobiliary continuum: non-alcoholic fatty liver disease, cholelithiasis ... what else? |
Abstract
PDF (Rus)
|
|
A. O. Bueverov |
| |
| No 5 (2021) |
Chronic acalculous cholecystitis and biliary dysfunction: how does clinical diagnosis affect management? |
Abstract
PDF (Rus)
|
|
Yu. A. Kucheryavyy, M. F. Osipenko |
| |
| No 5 (2021) |
Indicators of antioxidant status and oxidative stress in opisthorchiasis |
Abstract
PDF (Rus)
|
|
V. V. Tsukanov, E. G. Gorchilova, J. L. Tonkikh, A. V. Vasyutin, O. S. Rzhavicheva, O. A. Kolenchukova |
| |
| No 5 (2021) |
Clinical features of non-alcoholic steatohepatitis in patients with different glycemic status |
Abstract
PDF (Rus)
|
|
A. A. Shipovskaya, I. V. Kurbatova, P. V. Selivyorstov, V. N. Marchenko, V. G. Radchenko, O. P. Dudanova |
| |
| No 5 (2021) |
Obesity, non-alcoholic fatty liver disease, COVID-19: dangerous liaisons |
Abstract
PDF (Rus)
|
|
S. V. Tikhonov, V. D. Dekkanova, S. A. Vinnichuk, T. S. Fil, N. V. Bakulina |
| |
| No 5 (2021) |
Case of severe liver damage in COVID-19 |
Abstract
PDF (Rus)
|
|
E. Yu. Plotnikova, E. N. Baranova, M. S. Karyagina, O. A. Vorosova, K. A. Krasnov |
| |
| No 5 (2021) |
Difficulties of differential diagnosis of portal hypertension: case report |
Abstract
PDF (Rus)
|
|
T. V. Penkina, O. E. Berezutskaya, D. T. Dicheva, E. V. Partsvania-Vinogradova, V. S. Larina, R. M. Umyarova, D. V. Borzova, E. V. Ulyankina |
| |
| No 5 (2021) |
Possibilities of combined therapy in patients with functional biliary sphincter of Oddi disorder |
Abstract
PDF (Rus)
|
|
S. N. Mekhtiev, O. A. Mekhtieva, Z. M. Ibragimova, M. V. Ukhova, A. V. Volnukhin |
| |
| 1 - 66 of 66 Items |
|
